awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34109789-7F98F056-BD43-489D-965D-2AE028E006A7
Q34109789-7F98F056-BD43-489D-965D-2AE028E006A7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34109789-7F98F056-BD43-489D-965D-2AE028E006A7
Emerging treatments in type 2 diabetes: focus on canagliflozin.
P2860
Q34109789-7F98F056-BD43-489D-965D-2AE028E006A7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34109789-7F98F056-BD43-489D-965D-2AE028E006A7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b938615ce929f747a5c96cb4157d5c964af8e9a6
P2860
The human kidney low affinity Na+/glucose cotransporter SGLT2. Delineation of the major renal reabsorptive mechanism for D-glucose.